Edwards Lifesciences: FDA 510(k) clearances across all its applicant names
FDA lists 282 510(k) clearances, 19 PMA and 2 De Novo decisions across the 9 applicant names Caduvo groups under Edwards Lifesciences, first 1976, latest 2026. Median 510(k) review time across these names: 86 days. Since 2017 the median was 142 days, against 118 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 7 | 126 |
| 2013 | 7 | 143 |
| 2014 | 10 | 108 |
| 2015 | 6 | 92 |
| 2016 | 6 | 102 |
| 2017 | 4 | 92 |
| 2018 | 5 | 136 |
| 2019 | 8 | 110 |
| 2020 | 6 | 48 |
| 2021 | 4 | 128 |
| 2022 | 8 | 147 |
| 2023 | 9 | 168 |
| 2024 | 11 | 188 |
| 2025 | 9 | 107 |
| 2026 | 5 | 151 |
The 9 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | 135 | 19 | 1 | 1979–2026 |
| American Edwards Laboratories | 89 | 0 | 0 | 1980–1987 |
| Edwards Lifesciences | 21 | 0 | 1 | 2011–2026 |
| Edwards Laboratories | 12 | 0 | 0 | 1976–1980 |
| Baxter Edwards | 11 | 0 | 0 | 1993–2000 |
| Edwards Lifesciences Research Medical | 6 | 0 | 0 | 1998–2008 |
| Edwards Lifeciences, LLC | 3 | 0 | 0 | 2019–2022 |
| Edwards Lifesciences Services GmbH | 3 | 0 | 0 | 2007–2009 |
| Edwards Lifesiences, LLC | 2 | 0 | 0 | 2020–2022 |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 142 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 118 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DWF | Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass | 23 | 23 |
| DXG | Computer, Diagnostic, Pre-Programmed, Single-Function | 18 | 18 |
| DQK | Computer, Diagnostic, Programmable | 17 | 17 |
| DYB | Introducer, Catheter | 15 | 15 |
| DYG | Catheter, Flow Directed | 13 | 13 |
| KRH | Ring, Annuloplasty | 12 | 12 |
| DXN | System, Measurement, Blood-Pressure, Non-Invasive | 9 | 9 |
| DQO | Catheter, Intravascular, Diagnostic | 8 | 8 |
| DXC | Clamp, Vascular | 7 | 7 |
| DXE | Catheter, Embolectomy | 7 | 7 |
Plus 74 more product codes.
Review panels
- Cardiovascular (240)
- Gastroenterology and Urology (26)
- General Hospital (13)
- General and Plastic Surgery (9)
- Orthopedic (7)
- Anesthesiology (2)
- Neurology (1)
- Ophthalmic (1)
- Pathology (1)
- Radiology (1)
Most recent Edwards Lifesciences 510(k) clearances
| 510(k) | Device | Applicant name | Product code | Decision date | Review days |
|---|---|---|---|---|---|
| K254232 | ECLIPTIS Left Atrial Appendage Exclusion System (ECS135); ECLIPTIS Left Atrial Appendage Exclusion System (ECS140); ECLIPTIS Left Atrial Appendage Exclusion System (ECS145); ECLIPTIS Left Atrial Appendage Exclusion System (ECS150) | Edwards Lifesciences | PZX | 2026-06-26 | 179 |
| K251326 | Respiration Rate algorithm | Edwards Lifesciences, LLC | BZQ | 2026-06-11 | 408 |
| K260105 | Fogarty Spring Clips, Handleless Clamps, and Clamp Inserts | Edwards Lifesciences | DXC | 2026-06-05 | 143 |
| K254279 | Edwards eSheath+ introducer set | Edwards Lifesciences | DYB | 2026-04-17 | 108 |
| K253186 | HemoSphere Nano Monitor (HSNANO1) | Edwards Lifesciences, LLC | DQK | 2026-02-24 | 151 |
| K252533 | HemoSphere Alta Advanced Monitoring Platform (ALTAALL1; ALTACR1; ALTASR1) | Edwards Lifesciences | DQK | 2025-12-18 | 128 |
| K253034 | HemoSphere Stream Module | Edwards Lifesciences | DQK | 2025-10-21 | 29 |
| K251982 | Edwards MC3 Tricuspid annuloplasty ring (4900) | Edwards Lifesciences, LLC | KRH | 2025-09-23 | 88 |
| K251688 | Carpentier-Edwards Physio Annuloplasty Ring (4450) | Edwards Lifesciences, LLC | KRH | 2025-09-17 | 107 |
| K252364 | Edwards eSheath Optima introducer set | Edwards Lifesciences | DYB | 2025-08-29 | 31 |
272 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P260007 | PMA | Autus Size-Adjustable Valve | 2026-10-01 |
| P250019 | PMA | SAPIEN M3 Transcatheter Mitral Valve Replacement System | 2025-12-22 |
| P230013 | PMA | Edwards EVOQUE Tricuspid Valve Replacement System | 2024-02-01 |
| P220003 | PMA | PASCAL Precision Transcatheter Valve Repair System | 2022-09-14 |
| DEN190029 | De Novo | Adjunctive Open Loop Fluid Therapy Recommender | 2020-11-13 |
Recalls
187 product recalls in 73 recall events under these names; 22 initiated in the last five years.
66 product recalls in 8 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 3 initiated in the last five years. Most often: Bard Peripheral Vascular Inc (51), SPS Sterilization, Inc (8), Becton, Dickinson and Company (3).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
ClinicalTrials.gov lists 118 device studies (45 active or recruiting) with an industry lead sponsor under the 1 sponsor name below. Most recent:
- NCT06167213: ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral (Edwards Lifesciences; Not yet recruiting, started 2027-01)
- NCT07742839: CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance of the ECLIPTIS Left Atrial Appendage Exclusion System for Exclusion of the Left Atrial Appendage (LAA) During Concomitant Open-heart Cardiac Surgery. (Edwards Lifesciences; Not yet recruiting, started 2026-11-30)
- NCT07859709: The CLASP III TR CED Study (Edwards Lifesciences; Not yet recruiting, started 2026-10-15)
- NCT07858799: Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System (Edwards Lifesciences; Recruiting, started 2026-10)
- NCT07684313: TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study) (Edwards Lifesciences; Recruiting, started 2026-09-22)
| Lead sponsor name on ClinicalTrials.gov | Device studies |
|---|---|
| Edwards Lifesciences | 118 |
Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.
Parent company SEC filings
Edwards Lifesciences Corp (EW): EDGAR filings, CIK 1099800. The parent's SEC registrant is entered by hand for this group, not matched by name.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
Spun off from Baxter in 2000; American Edwards Laboratories and Baxter Edwards are its predecessors inside Baxter. Includes filings made before the spin-off. Edwards sold its Critical Care product group to BD on September 3, 2024; Critical Care filings made under the Edwards Lifesciences name before then cannot be split out. Left out: Edwards orthopaedics and pacemaker names (other businesses).
Sources
- https://en.wikipedia.org/wiki/Edwards_Lifesciences
- https://investors.bd.com/news-events/press-releases/detail/849/bd-completes-acquisition-of-critical-care-from-edwards-lifesciences
Frequently asked questions
How many FDA 510(k) clearances are listed across Edwards Lifesciences's applicant names?
FDA lists 282 510(k) clearances, 19 PMA and 2 De Novo decisions across the 9 applicant names Caduvo groups under Edwards Lifesciences, first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Edwards Lifesciences file under?
The names with the most 510(k) clearances in this group are Edwards Lifesciences, LLC (135); American Edwards Laboratories (89); Edwards Lifesciences (21); Edwards Laboratories (12); Baxter Edwards (11). The full list of 9 names is on this page.
How long does FDA take to clear Edwards Lifesciences 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 86 days. Since 2017 the median was 142 days, against 118 days for all cleared 510(k)s in the same product codes.
Does the Edwards Lifesciences count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
How many device clinical trials does Edwards Lifesciences sponsor?
ClinicalTrials.gov lists 118 device studies (45 active or recruiting) with an industry lead sponsor under 1 sponsor name Caduvo groups under Edwards Lifesciences. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.
Next steps
- See all 282 Edwards Lifesciences clearances with predicates and recalls
- Run predicate analysis for product code DWF, Edwards Lifesciences's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.
All parent companies · FDA device companies by applicant name · FDA product code lookup